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Bone marrow mesenchymal stem cells attenuate LPS-induced acute lung injury in mice
by promoting RvE1/ProD1 and modulating Treg/Th17 balance
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Abstract: Acute lung injury (ALI) and its severe form acute respiratory distress syndrome (ARDS) are respiratory failures caused by
excessive alveolar inflammation with high mortality. In this study, we investigated the effects of bone marrow mesenchymal stem cells
(BMSCs) on lung injury of lipopolysaccharide (LPS)-induced ALI and explored the associated mechanisms. BMSCs were isolated,
cultured, identified by staining with CD34 and CD44 surface markers. LPS-induced ALI mouse model was generated by injecting with
LPS and divided into ALI group and ALI+BMSCs group. Mice treated without any reagents were assigned as Control, mice transplanted
with BMSCs were assigned as BMSCs group. Regulatory T (Treg) and Th17 percentages were evaluated using flow cytometry. Proresolving
mediators (resolvin E1 (RvE1), protectin D1 (ProD1)) in lung tissue and cytokines (interleukin-6 (IL-6) and IL-17) in serum were
analyzed by ELISA. Myeloperoxidase (MPO) activity was determined. Cultured cells demonstrated typical characteristics of BMSCs.
BMSCs transplantation (ALI+BMSCs) obviously alleviated LPS-induced ALI in mice. BMSCs transplantation significantly decreased
MPO activity in LPS-induced ALI in mice compared to the Control group (p < 0.05). BMSCs transplantation markedly increased Treg
percentages and decreased dendritic cells (DCs) and Th17 cells percentages compared to those of the Control group (p < 0.05). BMSCs
transplantation remarkably enhanced RvE1 and ProD1 levels in LPS-induced ALI (ALI+BMSCs) compared to the ALI group (p < 0.05).
BMSCs transplantation significantly attenuated IL-6 and IL-17 levels in serum of mice treated with LPS (ALI+BMSCs) compared to
those of the ALI group (p < 0.05). In conclusion, BMSCs transplantation effectively attenuated LPS-induced pathological injury of ALI
in mice, at least partly through promoting proresolving mediators RvE1 and ProD1 and modulating the balance of Treg/Th17.
Key words: Acute lung injury, acute respiratory distress syndrome, mesenchymal stem cells, proresolving mediators, Treg, Th17 cells

1. Introduction
Acute lung injury (ALI) and its severe form- acute
respiratory distress syndrome (ARDS) is the respiratory
failure in critically ill patients resulted from excessive
alveolar inflammation (Matthay et al., 2019). Despite the
recent advances in lung protective ventilation strategies,
overall hospital mortality for ARDS patients was 34.0%,
with 60.0% patients diagnosed as severe ARDS (Liu et
al., 2018). Lack of effective pharmacological treatment
remains the main reason for high mortality of ARDS.
Imbalance of inflammatory response plays a key role
in occurrence and development of ALI, which makes the
pathogenesis extremely complex (Englert et al., 2019).
Among various immune cell types, CD4+ T cells play an
important part in the pathogenesis of ALI (Adamzik et
al., 2013; Weiskopf et al., 2020). Regulatory T (Treg) cells

have antiinflammatory roles mainly caused by contactdependent suppression and release of cytokines such as
transforming growth factor β (TGF-β) and interleukin-10
(IL)-10 that negatively impact other effector immune cells
(Weaver and Hatton RD, 2009). In contrast, Th17 cells play
a strong pro-inflammatory role through production and
release of cytokines, including IL-17, IL-6, tumor necrosis
factor α (TNF-α). Imbalance of Th17/Treg has been found
in a number of different autoimmune and inflammatory
diseases (Weaver and Hatton RD, 2009). A recent
prospective and observational study has demonstrated
that the ratio of Th17/Treg cells was positively related
to disease severity and 28-day mortality in patients with
ARDS (Yu et al., 2015). Furthermore, our previous data
with lipopolysaccharide (LPS)-induced ALI in mice also
demonstrated that lung dendritic cells (DCs) activation
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and Th1/Th17 polarization may play an important role in
the pathogenesis of ALI (Liu et al., 2012a; Liu et al., 2012b).
Therefore, strategies designed to restore Th17/Treg balance
may be a novel and effective therapeutic strategy in ARDS.
Mesenchymal stem cells (MSCs) have a wide range
of tissue sources and demonstrate a strong ability of
self-renewal and multi-directional differentiation
(Islam et al., 2019). A recent study (Qin and Zhao,
2020) has demonstrated that MSCs can ameliorate lung
injury in preclinical ARDS models, but the associated
mechanisms remain not fully understood. Data of MSCs
on differentiation of naive T cells into T cells subtypes
in ALI remain scarce. A recent study (Chen et al., 2020)
observed that MSCs could induce the development and
differentiation of Treg cells and modulate Th17/Treg
balance. However, modulation of MSCs on Th17/Treg
balance in ALI remains largely elusive.
The resolution of inflammation is an active course that
limits inflammation and prevents collateral injury. The
resolution of inflammation is mediated by the specialized
proresolving lipid mediators (SPMs), including lipoxins,
resolvins, and protectins (Fredman, 2019). This process
seems to be defective in several common inflammatory
lung diseases that are characterized by excessive
inflammation, such as ARDS (Levy and Serhan, 2014).
Recently, Gagliani et al. (2015) demonstrated that Th17
cells trans-differentiation into Treg cells may contribute
to the resolution of inflammation. Using single-cell RNAsequencing, Sharma, et al. (Sharma et al., 2020) reported
that Treg cells can produce specialized proresolving
lipid mediators and enhance inflammation resolution in
mouse models of atherosclerosis. Treg cells may tune the
regulation of tumor inflammation through lipoxin A4
(Zhang et al., 2010). However, the regulatory effect of SPMs
on the balance of Th17/Treg remains unknown in ALI.
Therefore, we hypothesized that bone marrow-derived
mesenchymal stem cells (BMSCs) might affect lung
injury through promoting SPMs and modulating Th17/
Treg balance in ALI. In this study, we aimed to construct
an LPS-induced ALI mouse model by intratracheally
administrating mice with LPS and to investigate effects of
BMSCs on expressions of SPMs and immune cells in lung
tissues of mice treated with LPS. The present study would
provide a theoretical basis for the application of BMSCs in
treating ALI clinically.
2. Materials and methods
2.1. Study design
After a week of adaptive feeding, LPS-induced ALI mouse
model was established. One week after modeling, BMSCs
were injected into tail vein. Twenty-four hour and 72h
after BMSCs injection, lung tissues of mice in each group
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were collected (and homogenized) for flow cytometry
assay to detect the proportion of DCs, Th17, and Treg cells.
ELISA was used to detect contents of lipoxin A4, regressin
E1 and protectin D1 in lung tissues, and hematoxylin and
eosin (H&E) staining was used to detect pathology of lung
tissues. At the same time, blood samples were also collected
for ELISA to detect serum levels of IL-17 and IL-6.
2.2. Isolation and culture of BMSCs
In the present research, BMSCs were isolated as
described by a former study (Chen et al., 2018), with a
few modifications. Briefly, BMSCs were isolated from the
bone marrow of femur and tibia deriving from C57BL/6
mouse (Experimental Animal Center of Nanjing Medical
University, Nanjing, China), using density-gradient
centrifugation separating method with Ficoll-Hypaque
(GE Bioscience, NJ, USA). The obtained cells were
washed, suspended using Dulbecco’s modified eagle
medium (DMEM, Gibco BRL. Co. Ltd., Grand Island,
New York, USA), and cultured with DMEM containing
15% fetal bovine serum (FBS, Gibco BRL. Co. Ltd.) and
1% streptomycin-penicillin (Beyotime Biotech., Shanghai,
China) at 37 ℃ and 5% CO2 for 24h. When the cultured
cells achieved a confluence of 80%, they were digested
using 0.25% trypsin (Beyotime Biotech.) and passaged
for 3 generations. The morphology for isolated BMSCs
was observed with an inverted microscope (Model:
IX73, Olympus, Tokyo, Japan). All processes for animal
experiments or tests were in accordance with NIH
guidelines and have been approved by the IACUC of
Nanjing Medical University.
2.3. Identification for BMSCs
The thirdly passaged cells were adjusted to density of
2×106 cells/mL medium, washed using phosphate buffer
solution (PBS), and stained with fluorescence-conjugated
antibodies specific for phycoerythrin (PE)-labeled CD44
and FITC-labeled CD34 (eBioscience, Santiago, CA, USA)
in dark and on ice for 20 min. Then, cells were washed
using PBS (supplementing with 1% FBS) for 2 times and
re-suspended with FACS Canto II flow cytometer (BD
Biosciences, Franklin Lakes, NJ, USA). The BMSCs were
negative for CD34 and positive for CD44.
2.4. Generation for LPS-induced ALI mouse model and
grouping
A total of 24 C57BL/6 mice, aging 6–8 weeks and weighting
20–25 g, were randomly divided into 4 groups (6 mice
each group), including the Control group, BMSC group,
ALI model group, and ALI+BMSCs group. Mice in control
were only injected with normal saline in airway. Mice in
BMSC group were injected with normal saline in airway
and 30 min later injected with BMSCs (106 cells per mouse)
into tail veins. Mice in ALI group were injected with LPS
(5 mg/ml storage solution) at final dosage of 1 μL/g body
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weight into airway and without BMSCs injection. Mice
in ALI+BMSC group were injected with LPS (5 mg/ml
storage solution) at final dosage of 1 μL/g body weight into
airway and 30 min later injected with BMSCs (106 cells per
mouse) into tail veins.
2.5. Lung injury assessment
Severity of lung injury was measured using lung tissue
histopathology and lung injury scores as previously
described (Liu et al., 2012a; Liu et al., 2012b). Mice were
anesthetized by intraperitoneally injecting with chloral
hydrate (0.5 mL/100 g body weight) and sacrificed. Lung
tissues of mice were stained using H&E method for carrying
out histopathological analysis. Briefly, the newly separated
lung tissues were fixed using 4% paraformaldehyde
(Beyotime Biotech.) at room temperature for 30min. Then,
lung tissues were dehydrated and embedded in paraffin
prior following cutting into section of 5 μm thickness.
Sections were stained using hematoxylin (10min, Jiancheng
Bioengineering Institute, Nanjing, China) and eosin (30s,
Beyotime Biotech.), as reported routine staining protocol
everywhere, and analyzed with a microscope (Model:
XC31, Olympus, Tokyo, Japan). A pathologist blind to
the experimental groups semiquantitatively assessed the
severity of lung injury (lung injury scores) according to
our previously published studies (Liu et al., 2012a; Liu et
al., 2012b).
2.6. Measurement for myeloperoxidase (MPO) activity
in lung tissues
MPO activity assay, an index of neutrophil infiltration
in pulmonary tissue, was carried out as descriptions of a
former study (Dong et al., 2012). In brief, MPO activity
was measured with myeloperoxidase assay kit (Model:
A044-1-1, Jiancheng Bioengineering Institute, Nanjing,
China) as instructed by manufacturer. MPO activity
was calculated using following formula: MPO activity
(U/g tissue wet weight) = (ODmeasurement-ODcontrol)/ (11.3a×
sampling amounts (g)b), among which “a” represented
reciprocal of slope, “b” represented amounts of wet tissues
in samples.
2.7. Bronchoalveolar lavage fluid (BALF) collection and
methylene blue-eosin staining
BALF of mice was collected as described by Wei-xu et al.
(Wei-xu et al., 2014; Wei-xu et al., 2016). Briefly, BALF
was collected at 24h and 72h post BMSCs injection. The
left trachea was exposed firstly then was cannulated using
silicone tubing attached to a needle (about 23 gauge) on a
syringe with a volume of 5 mL. Postinstillation of sterile
PBS (2 mL) through the trachea into lung tissues, BALF
was withdrawn and centrifuged. Finally, supernatants were
collected for following methylene blue-eosin staining.
Methylene blue-eosin staining was carried out as
reported by Wei-xu et al. (Wei-xu et al., 2014). Briefly,

smears of BALF were placed on the staining rack, 3-5
drops of methylene blue (Nanjing Jiancheng Biotech.,
Nanjing, China) were added, and stained about 1min
to fix the smears. Then, smears were stained by directly
adding 6-10 drops of eosin (Nanjing Jiancheng Biotech.),
gently shaking glass slide to mix dye solution, and dying
for 5 min. Finally, smears were washed with water for
60 s. After drying, cells on smears could be examined
microscopically. The cytoplasm was red, and the nucleus
was blue or purple.
2.8. Flow cytometry evaluation for dendric cells (DCs),
Treg and Th17 cells
Isolation of lung single cells was conducted as reported
previously (Liu et al., 2012a; Liu et al., 2012b). The DCs,
Treg, and Th17 cells were analyzed with flow cytometry
as reported previously (Liu et al., 2012a; Liu et al.,
2012b). In brief, the single lung cells were fixed with
4% paraformaldehyde (Beyotime Biotech.) at room
temperature for 30 min and permeabilized for 10 min.
The cells were washed using PBS and stained with FITClabeled anti-CD11c antibody (N418, Cat. No. 42-011481) and PE-labeled MHC-II antibody (AF6-120.1, Cat.
No. 12-5320-80) for analyzing DCs, using FITC-labeled
anti-CD3 antibody (UCHT1, Cat. No. 22-0304-72), APCCy7-labeled anti-CD4 antibody (GK1.5, Cat. No. A15384)
and PE-labeled IL-17A antibody (eBio64DEC17, Cat. No.
12-7179-41) for analyzing Th17 cells and using FITClabeled anti-CD4 antibody (GK1.5, Cat. No. 11-0041-82),
PE-labeled anti-Foxp3 antibody (FJK-16s, Cat. No. 125773-82) and APC-labeled CD25 antibody (CD25-3G10,
Cat. No. MHCD2505) for analyzing Treg cells overnight
in dark at 4 ℃. All these antibodies were purchased
from eBioscience (Santiago, CA, USA). Eventually, flow
cytometry was conducted on FACS Canto II flow cytometer
(BD Biosciences) and the percentages of DCs, Th17, and
Treg cells were evaluated with CELIQUEST software 5.1
(Biosciences, Franklin Lakes, NJ, USA).
2.9. ELISA for determining SPM and cytokines
In this study, the inflammation-associated factors in lung
tissues, including lipoxin A4 (LXA4), resolvin E1 (RvE1),
protectin D1 (ProD1), were measured. Meanwhile, the
cytokines in serum, including IL6 and IL-17, were also
measured using ELISA Kits (LkcxTech., Beijing, China) as
instructed by the manufacturers.
2.10. Statistical analysis
Data were assigned as mean ± standard deviation (SD) and
analyzed with SPSS software (version: 20.0, IBM Corp.,
Armonk, NY, USA). Differences among data of different
groups were analyzed using post hoc Turkey validated
ANOVA analysis. The p < 0.05 was assigned as significant
difference.
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3. Results
3.1. Culture and identification of BMSCs
After primary culture for 24h, the number of cells was small
and fusiform. When the third generation was passaged,
the number of cells increased gradually, and cells grew
in a colony like vortex (Figure 1A). The flow cytometry
results showed that a surface biomarker of BMSCs, CD44,
was positively expressed with a rate of 98.98% (Figure
1B). Similarly, we found that BMSCs do not express the
surface biomarker CD34 (Figure 1B). The cultured cells
demonstrated typical characteristics of BMSCs, therefore,
the isolated cells were identified as BMSCs.
3.2. BMSCs transplantation alleviated LPS-induced ALI
in mice
Under a light microscope, the alveolar structure of Control
group and BMSC group was clear, and the alveolar
septum was complete (Figure 2A) at both 24h and 72h of
culture. In ALI group, the normal structure of the alveolar
disappeared, the alveolar septum significantly thickened
with extensive formed hyaline membrane and some
inflammatory cells infiltrated at both 24h and 72h (Figure
2A). In ALI+BMSC group, alveolar structure was basically
clear, alveolar septum was slightly thickened, and only a
few inflammatory cells infiltrated into the pulmonary
interstitium at both 24h and 72h (Figure 2A). Similarly,
as shown in Figure 2B, lung injury scoring in ALI group
was significantly higher than that in control mice at 24h
and 72h (p < 0.01). Treatment of ALI group with BMSCs
significantly decreased lung injury score, compared

with that of ALI group (Figure 2B, p < 0.05). Totally, the
transplantation of BMSCs into airway could alleviate LPSinduced ALI in mice
3.3. BMSCs transplantation decreased MPO activity in
LPS-induced ALI in mice
The results indicated that MPO activity in lung tissues
of mice treated with LPS (ALI group) was significantly
higher compared to those of the Control group mice and
mice in BMSC group at 24h posttreatment (Figure 3, p <
0.01). However, MPO activity was significantly decreased
in lung tissues of mice in ALI+BMSC group compared
to those in ALI group at 24h posttreatment (Figure 3,
p < 0.05). Moreover, at 72h post LPS or normal saline
treatment, BMSCs transplantation (ALI+BMSC group)
could also remarkably reduce MPO activity compared to
that in ALI group (Figure 3, p < 0.05). Therefore, BMSCs
transplantation could decrease MPO activity in LPSinduced ALI in mice
3.4. BMSCs transplantation reduced neutrophils in
BALF of mice with LPS-induced ALI
The methylene blue-eosin staining findings showed
that there were fewer neutrophils in BALF of mice in
Control group and BMSCs group, at 24h and 72h post
LPS treatments (Figure 4A). While there were more
neutrophils in BALF of mice with LPS-induced ALI,
BMSCs transplantation obviously reduced the percentage
of neutrophils in BALF of mice (Figure 4A, p < 0.05).
Thus, transplantation of BMSCs could reduce the number
of neutrophils in BALF of mice with LPS-induced ALI.

Figure 1. Culture and identification of BMSCs. A. Morphological characteristics for isolated and cultured cells in the DMEM medium.
B. Identification and phenotypic analysis for BMSCs by staining with the surface biomarkers of CD44 and CD34.
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Figure 2. Lung tissue morphology of mice determined by the H&E staining. A. The H&E staining images for the alveolar structure of lung tissue in mice of different groups. B.
Statistical analysis for the H&E staining. Magnification, 400×.
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Figure 3. The statistical analysis for the MPO activity of lung
tissues of mice. The MPO activity was measured using the
Myeloperoxidase Assay Kit. *p < 0.05 vs. ALI or ALI+BMSCs
group. #p < 0.05 vs. ALI group.

3.5. BMSCs transplantation attenuated serum IL-6 and
IL-17 levels in mice with LPS-induced ALI
Compared to Control and BMSC group, IL-6 level (Figure
4B) and IL-17 level (Figure 4C) were significantly increased
in serum of mice in ALI group (p < 0.05), at 24h and 72h
post LPS treatments. However, the treatment of BMSCs
(ALI+BMSC group) could markedly attenuate IL-6 level
(Figure 4B) and IL-17 level (Figure 4C) compared with
those in serum of mice in ALI group (p < 0.05). These
results suggest that BMSCs transplantation could inhibit
the release of inflammatory cytokines such as IL-6 and IL17 in mice with LPS-induced ALI.
3.6. BMSCs increased the percentage of Treg cells and
decreased the percentage of DCs and Th17 cells in mice
with LPS-induced ALI
Flow cytometry assay was used to detect the percentage of
DCs, Treg, and Th17 cells. According to flow cytometry
plots for DCs (Figure 5A), the percentage of DCs in mice
of ALI group was remarkably increased compared to those
of the Control group and BMSCs group (Figure 5B, p <
0.05) at 24h post LPS treatment. BMSCs (BMSC+ALI)
markedly decreased the percentage of DCs than in mice of
the ALI group (Figure 5B, p < 0.05), at 24h post LPS and/or
BMSCs treatment. Also, according to flow cytometry plots
(Figure 6A), BMSCs (BMSC+ALI) significantly reduced
the percentage of Th17 cells in mice compared to those
in ALI group, at 72h post LPS and/or BMSCs treatment
(Figure 6B, p < 0.05). Moreover, flow cytometry plots
(Figure 7A) also demonstrated that BMSCs (BMSC+ALI)
significantly increased the percentage of Treg cells in mice
compared to those in ALI group, at 72h post LPS and/or
BMSCs treatment (Figure 7B, p < 0.05). Therefore, BMSCs
could increase the percentage of Treg cells and decrease
the percentage of DCs and Th17 cells.
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3.7. BMSCs transplantation modulated RvE1 and ProD1
in lung tissues of LPS-induced ALI in mice
In this study, proresolving lipid mediators, including RvE1,
ProD1, and LXA4, have been determined using ELISA
method. The results exhibited that RvE1 (Figure 8A) and
ProD1 levels (Figure 8B) were significantly lower, and LXA4
level (Figure 8C) was significantly higher in lung tissues of
mice with LPS-induced ALI compared to those in Control
and BMSCs group (p < 0.05), at both 24h and 72h post
LPS treatments. Interestingly, BMSCs (ALI+BMSC group)
remarkably enhanced RvE1 (Figure 8A) and ProD1 levels
(Figure 8B) compared to mice in ALI group (p < 0.05).
BMSCs transplantation (ALI+BMSC group) significantly
decreased LXA4 level (Figure 8C) in mice compared to
those in ALI group (p < 0.05). These results suggest that
BMSCs transplantation could modulate the production of
RvE1 and ProD1 in lung tissues of mice with LPS-induced
ALI.
4. Discussion
BMSCs show multi-directional differentiation potential
and immuno-regulation function, therefore, BMSCs are
widely applied in basic research for various inflammatory
diseases treatment, such as ALI (Chen et al., 2020).
Previously, we and other investigators have found that
activation of conventional DCs and Th17 polarization
may play an important role in the pathogenesis of ALI
(Liu et al., 2012a; Liu et al., 2012b; Verjans et al., 2013;
Yu et al., 2015), while Treg may play a protective role in
ALI (D’Alessio et al., 2009; Adamzik et al., 2013). In the
current study, we found that the treatment of BMSCs
obviously alleviated lung injury in mice with LPS-induced
ALI. Moreover, BMSCs treatment caused a significant
increase in the frequency of Treg cells and a decrease in
the percentage of Th17 cells and relevant proinflammatory
cytokines. We further provided evidence that BMSCs
transplantation markedly increased RvE1 and ProD1
levels in lung tissues of mice with LPS-induced ALI. These
results suggest that the protective effects of BMSCs on
ALI may be dependent, at least in part, on the promotion
of proresolving mediators RvE1 and ProD1 and on the
modulation of Th17/Treg balance.
In this study, BMSCs were obtained from bone marrow
and identified by microscopic examination and flow
cytometry. The results showed that the isolated cells have
typical BMSCs morphology and molecular phenotype.
Among all MSCs, BMSCs have been proven to demonstrate
stronger anti-inflammatory ability compared to the other
MSCs (Yang et al., 2018). Consistent with many previous
reports (Chen et al., 2018; Yang et al., 2018; Islam et al.,
2019; Chen et al., 2020; Qin and Zhao, 2020), we observed
that the integrity of alveolar in mice with LPS-induced ALI
was significantly improved, and inflammatory cells were

Figure 4. Effects of BMSCs transplantation on neutrophils in bronchoalveolar lavage fluid (BALF) and on serum levels of IL-6 and IL-17. A. Detection and statistical analysis for
neutrophils in BALF using methylene blue-eosin staining. B. The levels of levels of IL-6 in the serum of mice were decreased by ELISA. C. The levels of IL-17 in the serum of mice
were detected by ELISA. *p < 0.05 vs. ALI or ALI+BMSCs group. #p < 0.05 vs. ALI group.
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Figure 5. Effects of BMSCs transplantation on the percentage of DCs in mice with LPS-induced ALI. A. Flow cytometry plots for DCs at 24h and 48h posttreatments. B. Statistical
analysis of DCs cells. *p < 0.05 vs. ALI or ALI+BMSCs group. #p < 0.05 vs. ALI group.
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Figure 6. Effects of BMSCs transplantation on the percentage of Th17 in mice with LPS-induced ALI. A. Flow cytometry plots for Th17 cells at 24h and 48h posttreatments. B.
Statistical analysis of Treg cells. *p < 0.05 vs. ALI or ALI+BMSCs group. #p < 0.05 vs. ALI group.
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Figure 7. Effects of BMSCs transplantation on percentage of Treg in mice with LPS-induced ALI. A. Flow cytometry plots for Treg cells. B. Statistical analysis of the percentages of
the Treg cells at 24h and 72h posttreatments. *p < 0.05 vs. ALI or ALI+BMSCs group. #p < 0.05 vs. ALI group.
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Figure 8. Effects for BMSCs transplantation on the serum levels of RvE1 (A) and ProD1 (B) of
mice in different groups at 24h and 48h posttreatments. *p < 0.05 vs. ALI or ALI+BMSCs group.
#
p < 0.05 vs. ALI group.

significantly reduced after intervention of BMSCs. These
results confirmed that the treatment of BMSCs partially
prevented lung inflammatory process and lung injury in
mice with LPS-induced ALI. Further investigations are
needed to elucidate potentially protective mechanisms of
BMSCs in ALI.
CD4+ T cells play an important part in the pathogenesis
of ALI (Adamzik et al., 2013; Weiskopf et al., 2020). Some
previous studies (Weaver and Hatton RD, 2009; Adamzik
et al., 2013; Yu et al., 2015; Weiskopf et al., 2020) have
reported that imbalance of Th17/Treg was correlated to
inflammatory response and the severity of ALI. BMSCs
might display strong immuno-regulation ability. In
the present study, our results indicated that BMSCs
transplantation remarkably enhanced the percentage of
Treg cells and decreased the percentage of Th17 cells, both
of which might attenuate inflammatory responses of mice
with LPS-induced ALI. Therefore, BMSCs transplantation
demonstrated remarkable antiinflammatory effects on
LPS-induced ALI in mice through modulating the balance
of Treg and Th17 cells. Eventually, Th17/Treg balance was
re-generated in the lung tissues. A more recent study (Chen
et al., 2020) also reported that BMSCs administration
could reduce levels of proinflammatory cytokines and
influence the balance of Th17/Treg, which are consistent
with the present findings.
The acute inflammatory response is a complex
process including three phases: inflammation, normal

resolution, and postresolution phase (Fullerton and
Gilroy DW, 2016). It has been recognized that resolution
of inflammation is an active course that is initiated in
the first few hours after an inflammatory process begins
(Fullerton and Gilroy DW, 2016). Meanwhile, the
resolution of inflammation is also mediated by SPMs,
including lipoxins, resolvins, and protectins (Fullerton
and Gilroy DW, 2016). These proresolving molecules
promote the clearance of inflammatory cells from tissue
site and promote the restoration of functional homeostasis
(Leslie, 2015; Fullerton and Gilroy DW, 2016). The key
histological character in the resolution of inflammation
is loss of polymorphonuclear neutrophils from the local
inflammatory sites (Serhan et al., 2008). Our study showed
that BMSCs transplantation can significantly reduce MPO
activity in lung tissue of mice with LPS-induced ALI. These
findings suggest that BMSCs might have an important role
in proresolution of lung inflammation of ALI.
The proresolving mediators, RvE1, ProD1, could
inhibit inflammatory cell infiltration and suppress injury
of tissues (Serhan et al., 2008; Leslie, 2015; Fullerton
and Gilro, 2016). Therefore, the increased production of
RvE1 and ProD1 would be beneficial to the reduction of
inflammation. Zhang et al. (Zhang et al., 2020) proved that
RvE1 played anti-inflammatory functions in LPS-induced
heart injury. Duffield et al. (Duffield et al., 2006) reported
that ProD1 protected against inflammatory responses of
acute kidney injury in an animal model. However, the
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potential roles for RvE1 and ProD1 have not been clarified
in LPS-induced ALI animal model to our knowledge. We
further analyze several main SPMs to clarify potential
proresolution effect of BMSCs in LPS-induced ALI in
mice. In our study, we found that BMSCs transplantation
remarkably enhanced expressions of antiinflammatory
molecules, RvE1, and ProD1, in lung tissues of mice with
LPS-induced ALI. Actually, proresolving mediators are
usually produced in process of apoptotic cells clearance
by the immune system of the body (Schwab et al.,
2007). Therefore, we speculated that the enhancement of
proresolving mediators, RvE1, ProD1 was also triggered
by BMSCs through modulating immune responses.
Moreover, to our knowledge, this is the first study that
verifies proresolving mediators in the pathogenic process
of ALI in an animal model. However, the cause-and-effect
relationship between SPMs and Th17/Treg balance in ALI
has not been firmly established. Tregs may produce SPMs
and enhance inflammation resolution in mouse models
of atherosclerosis and tumor (Zhang et al., 2010; Sharma
et al., 2020). On the other hand, a more recent study
(Chiurchiù et al., 2016) observed that SPMs, including
resolvin D 1 (RvD1), resolvin D2 (RvD2), and maresin 1
(MaR1), can exert an important regulatory role on Th17
and Treg cells. Thus, we can not exclude the possibility that
SPMs and Treg cells may generate a positive feedback loop,
resulting in promotion of inflammation resolution in ALI
treated with BMSCs. Further research is needed to clarify
this relationship between SPMs and Th17/Treg cells.
This study also demonstrated a few limitations. First,
this study only identified the Treg and Th17 cells using the
flow cytometry analyses, which is a limitation of our study.
Actually, the Treg and Th17 cells could be simply verified

by analyzing the geometric mean fluorescence intensity
(MFI) of FoxP3 and IL-17 or other markers in cells.
Second, the CD3+CD4- cells (which mainly CD8+ and
gamma-delta T (Tgd+) cells) can also produce the IL-17 as
much as CD3+CD4+ cells do. However, this study has not
provided evidence that CD8+ and Tgd+ cells play any roles
in the pathogenesis of the ALI by producing the IL-17. In
the following study, we would verify the roles of CD8+ and
Tgd+ cells in ALI pathogenesis. Third, the sample size of
ALI model mouse is relatively small. We would involve
more large sample size for the animal model in a future
study.
5. Conclusion
Collectively, our findings showed that BMSCs
transplantation could effectively attenuate pathological
injury of LPS-induced ALI in mice, which at least partly
may be associated with modulation of Treg/Th17 balance
and promoted expression of RvE1 and ProD1.
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